Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million

benzinga.com/general/biotech/25/05/45281398/exclusive-mira-pharmaceuticals-board-approves-skny-pharma-acquisition-establishing-combined-enter

Mira Pharmaceuticals, Inc.’s (NASDAQ:MIRA) Board of Directors unanimously approved on Thursday the planned acquisition of SKNY Pharmaceuticals, Inc., following the completion of independent valuation reports on both companies.
In March, MIRA Pharmaceuticals signed a binding letter of…

This story appeared on benzinga.com, 2025-05-08 11:16:06.
The Entire Business World on a Single Page. Free to Use →